• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clonal hematopoiesis in primary immune thrombocytopenia.

作者信息

Wang Yanming, Yu Tianshu, Dong Qiaofeng, Liu Shuang, Yu Yafei, Zhao Hong Yu, Ma Ji, Dong Lin, Wang Liang, Ma Daoxin, Zhao Yajing, Hou Yu, Liu Xinguang, Peng Jun, Hou Ming

机构信息

Department of Hematology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China.

Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

出版信息

Blood Cancer J. 2022 Mar 15;12(3):40. doi: 10.1038/s41408-022-00641-5.

DOI:10.1038/s41408-022-00641-5
PMID:35293382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8924250/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37f/8924250/e5db9cfb7d47/41408_2022_641_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37f/8924250/e5db9cfb7d47/41408_2022_641_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37f/8924250/e5db9cfb7d47/41408_2022_641_Fig1_HTML.jpg

相似文献

1
Clonal hematopoiesis in primary immune thrombocytopenia.原发性免疫性血小板减少症中的克隆性造血
Blood Cancer J. 2022 Mar 15;12(3):40. doi: 10.1038/s41408-022-00641-5.
2
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation.唐氏综合征中发生的早发性克隆性造血伴随着免疫失调。
Blood Adv. 2021 Apr 13;5(7):1791-1796. doi: 10.1182/bloodadvances.2020003858.
3
Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.克隆性造血与新冠病毒疾病严重程度无显著关联。
Blood. 2022 Oct 6;140(14):1650-1655. doi: 10.1182/blood.2022015721.
4
Somatic mosaicism rewires transcriptional and epigenetic states in clonal hematopoiesis.体细胞嵌合现象重塑了克隆性造血中的转录和表观遗传状态。
Nat Genet. 2022 Oct;54(10):1453-1454. doi: 10.1038/s41588-022-01181-1.
5
Expanding approaches to detect clonal hematopoiesis.检测克隆性造血的扩展方法。
Haematologica. 2022 Aug 1;107(8):1739-1740. doi: 10.3324/haematol.2021.279818.
6
Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis.慢性心力衰竭患者因体细胞突变导致克隆性造血的造血改变。
Haematologica. 2020 Jul;105(7):e328-e332. doi: 10.3324/haematol.2019.224402. Epub 2019 Nov 7.
7
Introduction to a review series on mechanisms and clinical implications of clonal hematopoiesis.克隆性造血的机制及临床意义综述系列介绍
Blood. 2020 Oct 1;136(14):1567. doi: 10.1182/blood.2020007974.
8
[Hematopoiesis in children with Werlhof's disease immediately after operation].[韦尔霍夫病患儿术后即刻的造血功能]
Probl Gematol Pereliv Krovi. 1960 Jan;5:36-7.
9
[ON SOME PECULIARITIES OF WERLHOF'S DISEASE IN CHILDREN].[关于儿童韦尔霍夫病的一些特点]
Vopr Okhr Materin Det. 1963 Oct;8:29-34.
10
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19.克隆性造血不定潜能与 COVID-19 死亡风险。
Blood. 2022 Nov 3;140(18):1993-1997. doi: 10.1182/blood.2022018052.

引用本文的文献

1
Clinical characteristic of isolated thrombocytopenia in patients with bone marrow failure-related germline variants: a retrospective study from a single centre.骨髓衰竭相关种系变异患者孤立性血小板减少症的临床特征：一项单中心回顾性研究
Ann Med. 2025 Dec;57(1):2523560. doi: 10.1080/07853890.2025.2523560. Epub 2025 Jun 26.
2
Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia - Case Report.达雷妥尤单抗与罗米司亭联合治疗长期难治性原发性免疫性血小板减少症——病例报告
Immunotargets Ther. 2025 Jan 6;14:1-5. doi: 10.2147/ITT.S487895. eCollection 2025.
3
The impact of age and number of mutations on the size of clonal hematopoiesis.

本文引用的文献

1
[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].《成人原发性免疫性血小板减少症诊断与治疗中国指南（2020年版）》
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.
2
Clonal hematopoiesis and nonhematologic disorders.克隆性造血与非血液系统疾病。
Blood. 2020 Oct 1;136(14):1606-1614. doi: 10.1182/blood.2019000989.
3
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
年龄和突变数量对克隆性造血大小的影响。
Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2319364121. doi: 10.1073/pnas.2319364121. Epub 2024 Feb 15.
4
How we treat primary immune thrombocytopenia in adults.成人原发免疫性血小板减少症的治疗方法。
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
4
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.识别和治疗难治性 ITP：诊断困难和联合治疗的作用。
Blood. 2020 Feb 13;135(7):472-490. doi: 10.1182/blood.2019003599.
5
Clonal hematopoiesis in human aging and disease.人类衰老和疾病中的克隆性造血
Science. 2019 Nov 1;366(6465). doi: 10.1126/science.aan4673.
6
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome.发育不全性骨髓增生异常综合征的临床、组织病理学和分子特征。
Leukemia. 2019 Oct;33(10):2495-2505. doi: 10.1038/s41375-019-0457-1. Epub 2019 Apr 2.
7
New Insights from Studies of Clonal Hematopoiesis.从克隆性造血研究中获得的新见解。
Clin Cancer Res. 2018 Oct 1;24(19):4633-4642. doi: 10.1158/1078-0432.CCR-17-3044. Epub 2018 Apr 27.
8
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?新诊断免疫性血小板减少症的管理：我们能否改变治疗结果？
Blood Adv. 2017 Nov 14;1(24):2295-2301. doi: 10.1182/bloodadvances.2017009860.
9
[Chinese expert consensus on the diagnosis and treatment of aplastic anemia (2017)].再生障碍性贫血诊断与治疗中国专家共识（2017年版）
Zhonghua Xue Ye Xue Za Zhi. 2017 Jan 14;38(1):1-5. doi: 10.3760/cma.j.issn.0253-2727.2017.01.001.
10
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis.骨髓增生异常综合征中的剪接体基因突变：与造血克隆异常的分子联系
Genes Dev. 2016 May 1;30(9):989-1001. doi: 10.1101/gad.278424.116.